ASKA Pharmaceutical : May 31 2024 Licensing Agreement for Relugolix Combination Tablet for Endometriosis in the Gynecologic Disease Area
Press Release Licensing Agreement for Relugolix Combination Tablet for Endometriosis in the Gynecologic Disease Area TOKYO, May 31, 2024 -...
Source: marketscreener.com